Search For "covaxin"
Covaxin maker Bharat Biotech Chairman Krishna Ella, wife Suchitra Ella to
Updated : 4 years, 2 months ago IST
New Delhi [India], January 25 (ANI): Bharat Biotech Chairman Krishna Ella and co-founder Suchitra Ella will be conferred with Padma Bhushan on the 73rd Republic Day.
Read More
Deaths have been considerably reduced due to COVID-19 vaccination: ICMR
Updated : 4 years, 2 months ago IST
New Delhi [India], January 20 (ANI): Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.
Read More
SEC recommends regular market approval to Covaxin, Covishield for adults
Updated : 4 years, 2 months ago IST
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
Read More
COVID-19: Bharat Biotech requests healthcare workers to ensure only COVAXI
Updated : 4 years, 2 months ago IST
New Delhi [India], January 18 (ANI): Following reports of unapproved COVID vaccines being given to 15-18 year age group, Bharat Biotech on Tuesday requested healthcare workers to ensure that only COVAXIN is administered to individuals of the group.
Read More
COVID pandemic can't go on forever, will end soon: Expert
Updated : 4 years, 2 months ago IST
Washington [US], January 16 (ANI): As India achieved the milestone of cumulative vaccine coverage of 156 crores on the first anniversary of the nationwide COVID-19 vaccination drive that started on January 16, 2021, Dr Kutub Mahmoood, Scientist and Virologist from Washington, DC told ANI
Read More
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More
No COVID-19 vaccine shortage in Maharashtra, clarifies Union Health Minist
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): The Union Health Ministry on Friday issued a clarification that there is no COVID-19 vaccine shortage in Maharashtra as it has over 24 lakh unutilized doses of Covaxin available with it and an additional 6.35 lakh doses have been received today.
Read More
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bhara
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a universal vaccine for adults and children.
Read More
Facing vaccine shortage; no indication of flattening of curve: Maha Health
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 13 (ANI): Maharashtra is facing a shortage of Covaxin and Covishield, said state health minister Rajesh Tope on Thursday.
Read More
Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biot
Updated : 4 years, 2 months ago IST
New Delhi [India], January 12 (ANI): Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.
Read More
Administering of covid-19 'precaution doses' begins, frontline workers, se
Updated : 4 years, 2 months ago IST
New Delhi [India], January 10 (ANI): Amid the surge in COVID-19 cases driven by the Omicron variant, India began administering 'precaution doses' to healthcare, frontline workers and senior citizens with comorbidities on Monday.
Read More